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ABSTRACT
Background: Misoprostol is a synthetic prostaglandin E1 analogue which is now commonly used for 
induction of labor. Hyperstimulation is a complication of misoprostol that may lead to uterine rupture.
Objective: To find the association between misoprostol exposure for induction of labor with uterine 
rupture. 
Methods: Case were all women who delivered in Sardjito and affiliate Hospitals from January 2007 to 
November 2012 with the diagnosis of uterine rupture. Controls were taken randomly from the same 
hospital. Chi square test and logistic regression model were used for statistical analysis.
Result and Discussion: There were 53 cases of uterine rupture and 199 controls. The incidence of uterine 
rupture was 53 over 64,244 deliveries or 0,08%. Risk of of uterine rupture associated with misoprostol 
exposure was 1, 09 (CI 95% 0,52-2,2), while that of oxytocin exposure was 0,80 (CI 95% 0,35-1,85). Logistic 
regression analysis showed that the highest risk factor associated with uterine rupture was fetal weight > 
3500 (OR 3,46; 95% CI 1,48-8,56) followed by parity (OR 2,56;95%  CI 1,019-6,465) and  vacuum extraction 
(OR 2,45;95% CI 0,94-6,39).
Conclusion: There was no association between misoprostol exposure with uterine rupture. Fetal weight 
> 3500 gram, Parity more than 3, and vacuum extraction increased the risk of uterine rupture associated 
with misoprostol use.
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ABSTRAK
Latar belakang: Misoprostol adalah analog prostaglandin E1 sintetik yang sekarang banyak digunakan 
untuk induksi persalinan. Hiperstimulasi merupakan salah satu komplikasi induksi persalinan dengan 
misoprostol yang dapat mengakibatkan ruptur uterus .
Tujuan: Untuk mengetahui hubungan antara penggunaan misoprostol untuk induksi persalinan dengan 
kejadian ruptur uterus. 
Metode : Kasus adalah semua ibu melahirkan di RS Sardjito dan RS afiliasi dari Januari 2007 sampai 
November 2012 yang mengalami ruptur uteri. Sebagai kontrol adalah ibu melahirkan di rumah sakit yang 
sama yang tidak mengalami ruptur uteri yang diambil secara random dengan perbandingan 1:4. Chi square 
test dan logistic regression model digunakan untuk analisis statistik.
Hasil dan Pembahasan : Terdapat 53 kasus ruptur uterus yang memenuhi kriteria kelayakan dan 199 
kontrol. Insidensi ruptur uteri adalah 53 dari 64.244 persalinan atau 0,08%. Risiko ruptur uteri yang berhubungan 
dengan pemakaian misosprostol  adalah 1, 09 (CI 95% 0,52-2,2), sedang yang berhubungan dengan pemakaian 
oksitosin adalah 0,80 (CI 95% 0,35-1,85).   Analisis regresi logistik menunjukkan bahwa faktor risiko terbesar yang 
berhubungan dengan kejadian ruptur uteri adalah berat janin > 3500 (OR 3,46; 95% CI 1,48-8,56) disusul dengan 
paritas (OR 2,56;95%  CI 1,019-6,465) dan ekstraksi vakum (OR 2,45;95% CI 0,94-6,39).
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Kesimpulan: Tidak ada hubungan antara pemakaian misoprostol dengan kejadian ruptur uterus, tetapi 
berat janin > 3500 gram, paritas lebih dari 3, dan ekstraksi vakum menaikkan risiko ruptur uteri.
Kata kunci: Misoprostol, induksi persalinan, ruptur uteri, berat janin, paritas
INTRODUCTION
Misoprostol, a prostaglandin E1 analog, 
was first approved by the Food and Drug 
Administration (FDA) for the treatment of gastric 
ulcers, but it is now important in obstetric practice 
because of its uterotonic and cervical ripening 
actions. It has been now used widely to induce 
labor in term pregnancy and also to prevent 
postpartum hemorrhage.1 It is very effective for 
induction of labor either in premature rupture of 
membrane2, postdate pregnancy3 and pregnancy 
induced hypertension.4 It has also been used to 
induce labor in women with a history of previous 
cesarean section but the risk of rupture is still 
controversy.5
Although the use of misoprostol for 
induction of labor has been widely recognized, 
but there is no consensus about the optimum 
dose, frequency and route of administration for 
its safety.6 The recommended dose was 25 µg 
given not less than 3-4 hourly.7 
Hyperstimulation is one of the side effects of 
misoprostol can cause uterine rupture. There are 
several case reports of uterine rupture in women 
induced with misoprostol, especially with the 
history of secarea section.8 
Several studies and reviews have been 
conducted to assess the effectiveness and safety 
of misoprostol but until now there has been no 
research with large scale that examines incidence 
of uterine rupture associated with misoprostol 
induction. The use of misoprostol induction in 
pregnant women is still off label, because the 
data security is still lacking.9
The purpose of the recent stdudy was to 
find out wether misoprostol was assiciated 
with the risk of uterine rupture in women using 
misoprostol for induction of labor.
MATERIALS AND METHOD
Case control designed was used for the study. 
Data were taken from medical records for 5 years 
from January 2007 to November 2012 in Sardjito 
Hospital  and 5 affiliated Hospitals located at the 
Province of Jogjakarta and Central Java. 
Cases were all pregnant women with 
gestational age more than 28 weeks with uterine 
rupture due not to trauma. These were obtained 
from medical records with a diagnosis code ICD 
071.1 (International Classification of Diseases 
and related health problems) 10th revision version 
for 2007). Hospitals that data have not been 
computerized they were gathered manually was 
recorded from the delivery room. Controls were 
those who gave birth without uterine rupture 
and were taken randomly from the same hospital 
with a ratio 1:4. Those who had rupture due to 
trauma were excluded. 
Data were processed using SPSS version 
16 using chi-square test and logistic regression 
models  for statistical analysis.
RESULTS AND DISCUSSION
There were a total of 64,244 of deliveries 
during 5 years periode in the study hospitals. 
Fifty-three of them had uterine rupture and 
met the inclussion criteria (gestational age more 
than 28 completed weeks). Twelve from 53 
cases of uterine ruptures were associated with 
misoprostol use. None of them had a history of 
cesarean section. A total of 199 deliveries were 
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Table 1. Characteristics of Patients
Variable Frequency Percent
Age    (years)                         
> 35 
≤ 35 
44
208
17.5
82.5
Parity                                      
> 3
≤ 3
26
226
10.3
89.7
 Fetal weight (g)                    
 > 3500 
≤ 3500 
25
227
9.9
90.1
Misoprostol-induced    
Yes
No
54
198
21.4
78.6
Exposure to oxytocin             
Yes
No
44
208
17.5
82.5
Vacuum extraction       
Yes
No
23
229
9.1
90.9
Uterine Rupture                              
Yes
No
53
199
21
79
taken as control. A total of 252 samples then 
used for further analysis.
There were 54 women who were induced 
with misoprostol (21,4%), 44 were exposed to 
oxytocin (17,5%), 23 to vacuum extraction  (9,1%) 
and  53 (21 %) women had  uterine rupture (Table 
1).
The association between misoprostol 
and uterine rupture was the main interest to 
investigate, as shown on table 2. It seemed that 
the exposure of misoprostol did not increase the 
occurrence of uterine rupture. Uterine rupture 
is a catastrophic condition potetially leading to 
death both for mother and fetus if not promptly 
and adequately managed. The incidence of 
uterine rupture during 5 years period in this 
study was 0.08 % (8 per 10,000 deliveries). It 
was similar with other reports that ranged from 
0.07% to 0.17%.10 The incidence was even lower 
for the unscarred uterus, 0.007% (0.7 per 10,000 
deliveries) but it was much more higher for the 
scarred uterus.11 
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Table 2. Exposure of misoprostol to uterine rupture 
Variable Rupture No rupture OR (CI 95%) P value
Misoprostol
Yes
12 42
1, 09 (0,52-2,26) 0,80
Misoprostol
No
41 157
The rate of uterine rupture was much 
higher in an attempt to do a vaginal delivery 
after cesarean section if misoprostol is used. 
One study showed that there were four out of 
41 patient underwent uterine rupture.12   Other 
study found that the uterine rupture rate for 
patients attempting vaginal birth after cesarean 
section was significantly higher 5.6%  in those 
who received misoprostol, than in those who did 
not, 0.2%.13  
This present study showed that induction of 
labor using misoprostol did not increase the rate 
of uterine rupture because none of our patients 
induced by misoprostol had a history of previous 
cesarean section. In addition to history of scarred 
uterus, doses of misoprostol might also influence 
the occurrence of uterine rupture. The use of 
100 µg gave rise to 2 out 29 patient undergoing 
uterine rupture (6.89%) compared to none 
among 28 patients induced by Folley catheter.14 
Another study found that there were two cases 
out of 64 women of who had uterine rupture 
induced with 100 µg compared to none when 
induced with 50 µg.15 As our data on the dose 
of misoprostol were incomplete then the effect 
of dose on the occurrence of uterine rupture 
couldn’t be analyzed.
Further analysis demonstrated that fetal 
wight increased significantly the rate of uterine 
rupture, followed by vacum extraction and 
parity more than three although they were 
not statistically significant (Table 3). Oxytocin 
exposure and maternal age did not have any 
effect on the occurrence of uterine rupture. 
Table 3. Bivariate analysis showing variables potential to induce uterine rupture.
No Variables Ruptur No ruptur OR (CI 95%) p
1 Oxytocin exposure:
Yes 8 36 0.80 (0.35-1.85) 0.61
No 45 163
2 Vacuum Extraction:
Yes 8 15 2.18 (0.87-5.46) 0,09
No 45 184
3 Maternal age (years):
> 35 11 33 1.31 ( 0.61-2.82) 0.47
≤ 35 42 166
4 Parity
> 3 9 17 2.19 (0.91-5.24 0.07
≤ 3 44 182
5 Fetal weight
> 3500 gr 11 14 3,46 (1,46-8,16) 0,03
≤ 3500 gr 42 185
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Table 4. Multivariate analysis of variables potentially induce uterine rupture
Variabel OR CI (95%) p
Misoprostol  induction       
Yes
No
1.15
1 0,53-2,49 0,71
Parity                                       
> 3
≤ 3
2,56
1 1,02-6,46 0,04
Fetal Weight                      
> 3500 gr
≤ 3500 gr
3,56
1
1,48-8,56 0,01
Oxytocin exposure              
Yes
No
0,80
1 0,33-1,92 0,62
Vaccum Extraction      
Yes
No
2,45
1
0,94-6,39 0,06
To find out variables that gave the greatest 
influence on the occurrence of uterine rupture, 
a multivariate logistic regression model was 
caried out. It was shown that fetal weight more 
than 3500 g, parity more than three and vaccum 
extraction were consistently related to uterine 
rupture. (Table 4).
The cochrane systematic review conducted 
by Alfirevic found that oral misoprostol was 
effective for induction of labor, but the data 
were not big enough to draw a conclusion on 
the safety of its use.16 Review conducted by 
Homfrey and Munzozini concluded that it was 
not enough evidence to say that misoprostol 
under the tongue was safe for inducing labor. The 
authors suggested to do more studies with larger 
samples.17
The main risk factor found in this study was 
increased fetal weight more than 3,500 grams 
and it seemed to be clinically and statistically 
significant. The same result was demonstrated by 
Jastrow et al. who found that increased incidence 
of uterine rupture was influenced by increased 
fetuses fetal weight more than 3500 grams and 
much higher in fetus weighing more than 4000 
grams.18
The present study showed that maternal age 
didn’t increased the risk of uterine rupture as the 
other investigator reported.19 Oxytocin was not 
asscociated with the increased risk for uterine 
rupture and even with hyperstimulation. This 
might be due to the  limitted sample in the study 
with small dose. Higher dose had been reported 
to be asscoiated with maternal hyperstimulation 
but no rupture was encountered.20
The risk of getting rupture associated with 
the use vacuum extraction to deliver baby in 
this study was 2.45 (95%, 0.94-6.39). which is 
not statistically significant but clinically important. 
Five cases who received misoprostol might have 
ruptured before vacuum extraction was done. 
Vacuum extraction was claimed to be a risk factor for 
uterine rupture.21 Parity more than three increased 
the rate of uterine rupture by 2.56 fold. This might 
be attributed to the thinner uterine wall as more 
child birth took place as proposed by Gardeil.22
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CONCLUSSION
This study concluded that misoprostol was 
not asscociated with the incraesed rate of uterine 
rupture. On the other hand, fetal weight, parity 
and exposure to vacuum extraction during the 
second stage were dominant factors attributable 
to uterine rupture.
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